• Marzieh Tajmirriahi, Maryam Masjedi Esfahani, Zahra Amouaghaei, Nahid Mansori, Pantea Miralaei, Sahar Sadat Lalehzar, Peiman Shirani, and Mohammad Saadatnia.
• Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
• J Res Med Sci. 2023 Jan 1; 28: 1010.

BackgroundSome studies showed the cerebrovascular manifestation in patients with recently pandemic coronavirus 2 named the coronavirus disease 2019 (COVID-19). However, there are rare reports about stroke subtypes in these patients. Here, we reported the stroke subtype in patients with laboratory-confirmed diagnosis of COVID-19 and treated at our hospitals, which are located in Isfahan, Iran.Materials And MethodsThis is a retrospective, observational case series. Data were collected from March 01, 2020, to May 20, 2020, at three designated special care centers for COVID-19 of Isfahan University of Medical Sciences. The study included 1188 consecutive hospitalized patients with laboratory-confirmed diagnosis of COVID-19.ResultsOf 1188 COVID-19 patients, 7 (0.5%) patients developed stroke. Five (0.4%) had ischemic arterial stroke, 1 (0.08%) hemorrhagic stroke and 1(0.08 %) cerebral venous and sinus thrombosis. Sixty percent of ischemic stroke were cardioembolic stroke (CE) and the rest 2 (40%) were embolic stroke of undetermined source. Three male patients (40%) had stroke as a presenting and admitted symptom of COVID-19. Four patients (57%) had severe COVID-19.ConclusionStroke was an uncommon manifestation in COVID-19 patients. CE was a common subtype of stroke in COVID-19 patients in our centers.Copyright: © 2023 Journal of Research in Medical Sciences.

4 keywords...

hide…